Antiviral Res
- HUSSAIN S, Meijer A, Govorkova EA, Dapat C, et al
Global update on the susceptibilities of influenza viruses to neuraminidase
inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.
Antiviral Res. 2025 Jun 24:106217. doi: 10.1016/j.antiviral.2025.106217.
Clin Infect Dis
- HARUN MGD, Sumon SA, Anwar MMU, Mohona TM, et al
Infection Prevention and Control Knowledge, Attitudes, and Practices of
Healthcare Workers in Tertiary Care Hospitals in Bangladesh During Coronavirus
Disease 2019: A Multicenter Cross-sectional Survey.
Clin Infect Dis. 2025 Jun 25:ciaf246. doi: 10.1093.
- DUONG KS, Henry SS, Duong TQ
SARS-CoV-2 infection increases long-term risk of pneumonia in an urban
population: an observational cohort study up to 46 months post-infection.
Clin Infect Dis. 2025 Jun 25:ciaf345. doi: 10.1093.
- OPENSHAW JJ, Chen J, Rodriguez R, Gottlieb M, et al
The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Reinfection on Long-Term Symptoms in the Innovative Support for Patients With
SARS-CoV-2 Infections Registry (INSPIRE).
Clin Infect Dis. 2025 Jun 18:ciaf225. doi: 10.1093.
Emerg Infect Dis
- TARBUCK NN, Garushyants SK, McBride DS, Dennis PM, et al
Persistence of SARS-CoV-2 Alpha Variant in White-Tailed Deer, Ohio, USA.
Emerg Infect Dis. 2025;31:1319-1329.
Infect Control Hosp Epidemiol
- WHITELEY TD, Stimson J, Brown CS, Robotham JV, et al
Modeling the impact of health care worker masking to reduce nosocomial SARS-CoV-2
transmission under varying adherence, prevalence, and transmission settings.
Infect Control Hosp Epidemiol. 2025 Jun 27:1-7. doi: 10.1017/ice.2025.
Int J Infect Dis
- CHAPMAN A, Barouch DH, Lip GYH, Pliakas T, et al
Risk of severe outcomes from COVID-19 in comorbid populations in the Omicron era:
a systematic review and meta-analysis.
Int J Infect Dis. 2025 Jun 24:107958. doi: 10.1016/j.ijid.2025.107958.
- PAUL E, Brown GW, Dechamps M, Kalk A, et al
Corrigendum to "COVID-19: an 'extraterrestrial' disease?", [International Journal
of Infectious Diseases, Volume 110, 155-159, September 2021].
Int J Infect Dis. 2025;158:107951.
- TEODORO LI, Ovsyannikova IG, Grill DE, Poland GA, et al
Seroprevalence of RSV Antibodies in a Contemporary (2022 - 2023) Cohort of
Adults.
Int J Infect Dis. 2025 Jun 21:107964. doi: 10.1016/j.ijid.2025.107964.
- JOSEPH JT, Grau-Sepulveda M, Griffith BC, Lufes N, et al
Evaluating the introduction of COVID-19 oral antivirals through a test and treat
program: outcomes from a cohort study in four African countries.
Int J Infect Dis. 2025 Jun 19:107956. doi: 10.1016/j.ijid.2025.107956.
- TSUCHIHASHI Y, Tamura K, Matsumoto K, Mitsushima S, et al
Comparative analysis of streptococcal toxic shock syndrome caused by three
beta-hemolytic streptococcal species in Japan.
Int J Infect Dis. 2025 Jun 18:107962. doi: 10.1016/j.ijid.2025.107962.
- ESTILL J, Belayneh EG, Beale S, Keiser O, et al
Estimation of the number of people affected by post COVID-19 condition in
Switzerland in 2023: A mathematical model.
Int J Infect Dis. 2025 Jun 18:107963. doi: 10.1016/j.ijid.2025.107963.
J Med Virol
- SANCHEZ-SIMARRO A, Carretero D, Grau B, Martinez-Perez M, et al
Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a
Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and
Healthy Individuals.
J Med Virol. 2025;97:e70463.
- WANG Y, Sun H, Liu Y, Song Y, et al
TMEM106B Supports Viral Entry and Syncytia Formation Mediated by the Spike
Proteins From Omicron BA.2.86 and JN.1.
J Med Virol. 2025;97:e70439.
- BARY F, Karunananda MV, Jeewandara C, Danasekara S, et al
Changes in Population Immunity to Omicron SARS-CoV-2 Variants and Selected
Sarbecoviruses From 2020 to 2023 in Urban Colombo, Sri Lanka.
J Med Virol. 2025;97:e70462.
JAMA
- GRUNEBAUM A, Chervenak FA
Professional Responsibility for COVID-19 Vaccination in Pregnancy.
JAMA. 2025 Jun 25. doi: 10.1001/jama.2025.11328.
Lancet
-
Global, regional, and national trends in routine childhood vaccination coverage
from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global
Burden of Disease Study 2023.
Lancet. 2025 Jun 24:S0140-6736(25)01037-2. doi: 10.1016/S0140-6736(25)01037.
- PAIL O, Lin MJ, Anagnostou T, Brown BD, et al
Cancer vaccines and the future of immunotherapy.
Lancet. 2025 Jun 17:S0140-6736(25)00553-7. doi: 10.1016/S0140-6736(25)00553.
Lancet Infect Dis
- LIU JW, Lai CC, Hsueh PR
Resurgence of human metapneumovirus in the post-COVID-19 era: pathogenesis,
epidemiological shifts, clinical impact, and future challenges.
Lancet Infect Dis. 2025 Jun 20:S1473-3099(25)00240.
MMWR Morb Mortal Wkly Rep
- DIAZ MH, Hersh AL, Olson J, Shah SS, et al
Mycoplasma pneumoniae Infections in Hospitalized Children - United States,
2018-2024.
MMWR Morb Mortal Wkly Rep. 2025;74:394-400.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016